Lipoprotein(a) and Cardiovascular Disease | G...

Up next

Winning Hearts, Minds, and Policy with Strategic Communications | PBM Reform

Many pharmacy leaders focus on legislation and lobbying. Why is strategic communication on social media equally important?

. 42min 13sec

Easing Prior Auth Pain Points for Specialty Pharmacies with Develop Health | NASP Specialty Pharmacy Podcast

In this episode of the NASP Podcast, host Sheila Arquette, President & CEO of NASP, speaks with Nico Kernick, Head of Growth and Operations at Develop Health. They discuss the ways AI is reducing friction and increasing transparency in the prior authorization process for provider ... Show more

. 22min 0sec

Recommended Episodes

Lipids and cardiovascular disease

RCGP eLearning Podcast

In this podcast, Dr Emma Nash talks to Professor Derek Connolly about cardiovascular disease and lipid management. Measuring and interpreting lipid profiles and when to initiate treatment are discussed. Professor Connolly takes us through the various treatment options and their r ... Show more

. 25min 14sec

#174 Lp(a) and ASCVD Risk: 5 Pearls Segment

Core IM | Internal Medicine Podcast

What does Lipoprotein(a) tell us that a standard lipid panel doesn’t? Should we be testing everyone for it? Dive into the genetics, clinical implications, and evolving management strategies for Lp(a). Learn how to interpret results, counsel patients, and navigate topics with limi ... Show more

. 43min 20sec

How to Improve Dyslipidemia Care in Underresourced Populations

Medscape InDiscussion: Dyslipidemia

Drs Larry Sperling and Karol Watson discuss health equity and social determinants of health for populations with dyslipidemia. Relevant disclosures can be found with the episode show notes on Medscape.com ( https://www.medscape.com/viewarticle/958746). The topics and discussions a ... Show more

. 17min 14sec

#229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB

The Peter Attia Drive

View the Show Notes Page for ...

. 1h 18min